Eli Lilly & Co

LLYNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.072 T

$1,138.28 +2.02%

Close of 14 Sept 2026

Revenue

$65.2B

#62 by revenue

Earnings

$20.6B

#22 by earnings

Shares outstanding

941,357,065

Latest filing cover page

P/E ratio

51.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#1Eli Lilly & CoLLY$1.07T
#2Johnson & JohnsonJNJ$641.8B
#3AbbVieABBV$462.6B
#4Merck & Co.MRK$357.4B
#5NovartisNVS$265.2B

What if Eli Lilly & Co were worth as much as…

Open the what-if tool →

Gold $29.9T

$31,729.25

Per share 27.9× higher

Bitcoin $1.56T

$1,659.39

Per share 1.46× higher

Nvidia $5.08T

$5,400.86

Per share 4.74× higher

Or at a round number

$2.00T $5.00T $10.0T $20.0T

Where these numbers come from

Share counts and financials for Eli Lilly & Co are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 15 Sept 2026. Read the methodology.